Inhaled high dose nitric oxide is a safe and effective respiratory treatment in spontaneous breathing hospitalized patients with COVID-19 pneumonia

Bijan Safaee Fakhr(University of Alabama at Birmingham Hospital), Robert M. Kacmarek(Harvard University), Vibhu Parcha, L. Keith Scott(Louisiana State University Health Sciences Center Shreveport), Oluwaseun Akeju(Harvard University), Edward A. Bittner(Harvard University), Donald B. Bloch(Harvard University), Riccardo Pinciroli, Steffen B. Wiegand, Yusuke Miyazaki(Massachusetts General Hospital), Jeanne B. Ackman(Harvard University), Lauren E. Gibson, Stefano Gianni, Elizabeth Caskey, Anna Fischbach(Massachusetts General Hospital), Kathryn A. Hibbert(Duke University), Marvin G. Chang, Robert M. H. Grange(Harvard University), Lisa Traeger(University Hospital Münster), Fumito Ichinose(Harvard University), Josanna Rodriguez‐Lopez(Harvard University), Eizo Marutani(Harvard University), Benjamin Corman(Massachusetts General Hospital), Takamitsu Ikeda(Harvard University), Warren M. Zapol, Pankaj Arora(University of Alabama at Birmingham), Martin Capriles, Lorenzo Berra(Massachusetts General Hospital), Peggy S. Lai(Harvard University), Raffaele Di Fenza, Caio C. A. Morais, Ryan W. Carroll(Northwestern University), Eduardo Diaz Delgado, Reginald E. Greene, H. Wanderley, Stuart N. Harris, Grant Larson(University of California San Diego), Kimberley Hutchinson, Ariel Mueller(Harvard University)
Nitric Oxide
August 13, 2021
Cited by 68


Related Papers